{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-018094","form_type":"8-K","ticker":"ALXO","cik":"0001810182","company_name":"ALX ONCOLOGY HOLDINGS INC","filed_at":"2026-01-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.260699+00:00","generated_at":"2026-05-16T09:20:16.228298+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"ALX Oncology increases inducement plan share reserve by 1.3M shares to total 2.8M shares","bullets":["Board amended 2025 Inducement Equity Incentive Plan to reserve an additional 1,300,000 shares of common stock.","Total shares reserved under the inducement plan now 2,800,000.","Amendment adopted without stockholder approval per Nasdaq inducement award exception rules.","Awards under the plan will be granted only to new employees as material inducement to join the Company.","Plan terms are substantially similar to the Amended and Restated 2020 Equity Incentive Plan."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-018094","json":"https://secwatch.observer/filing/0001193125-26-018094.json","markdown":"https://secwatch.observer/filing/0001193125-26-018094.md","text":"https://secwatch.observer/filing/0001193125-26-018094.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526018094/0001193125-26-018094-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526018094/alxo-20260121.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T09:20:16.228298+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}